|
Multiplex Detection of Mutations in Myeloproliferative Disorder and Leukemia Pati
|
1R43CA130501-01
|
$256,027
|
YE, FEI
|
AMBION DIAGNOSTICS, INC.
|
|
Bead-array for rapid risk-stratification in leukemia
|
5R44CA115129-04
|
$465,644
|
YE, FEI
|
AMBION DIAGNOSTICS, INC.
|
|
Bay Area Tumor Institute CCOP
|
2U10CA045461-18
|
$480,000
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
SV40 Pathogenesis of Human Infections
|
5R01CA104818-04
|
$464,495
|
BUTEL, JANET
|
BAYLOR COLLEGE OF MEDICINE
|
|
NR4A Nuclear Receptor Function in Leukemia
|
5R01CA111411-02
|
$258,529
|
CONNEELY, ORLA
|
BAYLOR COLLEGE OF MEDICINE
|
|
SPORE in Lymphoma
|
1P50CA126752-01
|
$2,266,618
|
Heslop, Helen
|
BAYLOR COLLEGE OF MEDICINE
|
|
Mechanisms of Cellular Transformation by HTLV-1 TAX
|
5R01CA077371-09
|
$268,279
|
Marriott, Susan
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
1P30CA125123-01
|
$1,500,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-01S1
|
$111,700
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Mitotic Regulation of Apoptosis in Leukemia
|
5R01CA109478-02
|
$201,652
|
PATI, DEBANANDA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Regulation of Cell Growth by RNA Binding Proteins
|
5R01CA100070-05
|
$254,009
|
TIMCHENKO, NIKOLAI
|
BAYLOR COLLEGE OF MEDICINE
|
|
Regulation of p21waf1/cip1 by Rho and Ras signaling
|
5R01CA030721-05
|
$182,278
|
OLSON, MICHAEL
|
BEATSON INSTITUTE FOR CANCER RESEARCH
|
|
Virginia Mason Community Clinical Oncology Program
|
3U10CA035192-24S1
|
$80,000
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-24
|
$391,000
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Training Patients and Partners for HSCT: A Novel Coping Skills Intervention
|
1R03CA130725-01
|
$84,500
|
Lawsin, Catalina
|
BERNARD M. BARUCH COLLEGE
|
|
Eastern Cooperative Oncology Group
|
2U10CA080775-09
|
$128,678
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Oncogene-Induced Evasion from Apoptosis
|
5R01CA105306-03
|
$318,352
|
KHOSRAVI-FAR, ROYA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Role of Gab2 and Shp2 in Hematopoietic Signalling
|
5R01CA114945-10
|
$394,394
|
NEEL, BENJAMIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Signal Transduction by Non-transmembrane PTPs
|
5R37CA049152-19
|
$502,926
|
NEEL, BENJAMIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Distinct acute myeloid leukemia subclasses with CEBPA mutations
|
1R01CA118316-01A1
|
$403,102
|
TENEN, DANIEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
INTERACTING FACTORS IN HEMATOPOIESIS AND LEUKEMIA
|
5P01CA072009-10
|
$1,583,949
|
TENEN, DANIEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
MOLECULAR BIOLOGY OF MYELOID DIFFERENTIATION
|
5R01CA041456-22
|
$441,601
|
TENEN, DANIEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
High resolution analysis of linear genomic DNA in Parallel nanochannel arrays
|
5R43CA120611-02
|
$132,000
|
cao, han
|
BIONANOMATRIX, LLC
|
|
Cyclic AMP-mediated apoptosis in lymphoid malignancies
|
5R01CA106705-03
|
$241,199
|
LERNER, ADAM
|
BOSTON MEDICAL CENTER
|
|
Regulation of apoptosis by PI 3-kinase/Akt signaling
|
5R01CA018689-31
|
$457,492
|
COOPER, GEOFFREY
|
BOSTON UNIVERSITY
|
|
Role of P80 pro-IL-16 in T Cell Malignancy
|
5R01CA100925-03
|
$282,526
|
ZHANG, YUJUN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Oncogenic NOTCH Signaling
|
5P01CA119070-02
|
$968,589
|
ASTER, JON
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Pathogenesis of Notch Leukemia
|
5R01CA082308-09
|
$433,640
|
ASTER, JON
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alternative Entry Mechanism for Pathogenic Retroviruses
|
5R01CA104266-04
|
$259,594
|
CUNNINGHAM, JAMES
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Aspartame Intake and the Risk of Cancer
|
1R03CA130054-01
|
$116,101
|
SCHERNHAMMER, EVA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
SIGNAL TRANSDUCTION AND CELL DEATH REGULATION
|
5P01CA069381-12
|
$1,703,076
|
REED, JOHN
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA030199-27
|
$3,387,817
|
VUORI, KRISTIINA
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
Spectral imaging for automated malignant blast counting
|
5R44CA088684-07
|
$1,006,481
|
LEVENSON, RICHARD
|
CAMBRIDGE RESEARCH AND INSTRUMENTATION
|
|
CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs
|
2U10CA037429-22
|
$14,335,283
|
Coltman, Charles
|
CANCER THERAPY AND RESEARCH CENTER
|
|
Carle Cancer Center Community Clinical Oncology Program
|
3U10CA035195-24S1
|
$120,000
|
ROWLAND, KENDRITH
|
CARLE CLINIC ASSOCIATION, P C
|
|
Carle Cancer Center Community Clinical Oncology Program
|
5U10CA035195-24
|
$693,116
|
ROWLAND, KENDRITH
|
CARLE CLINIC ASSOCIATION, P C
|
|
Eastern Cooperative Oncology Group Studies
|
5U10CA014548-33
|
$413,938
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Non-natural Nucleoside Inhibitors of DNA Polymerases
|
5R01CA118408-03
|
$229,214
|
BERDIS, ANTHONY
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Mechanism of Steroid Action in Lymphoid Malignancy
|
5R01CA042755-21
|
$311,299
|
DISTELHORST, CLARK
|
CASE WESTERN RESERVE UNIVERSITY
|
|
CWRU/UHICC Phase I Trials of Anticancer Agents
|
5U01CA062502-14
|
$560,898
|
DOWLATI, AFSHIN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
2P30CA043703-18
|
$5,104,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Cedar Rapids Oncology Project
|
5U10CA052352-18
|
$423,530
|
WIESENFELD, MARTIN
|
CEDAR RAPIDS ONCOLOGY PROJECT
|
|
C/EBP-epsilson: Role in Myeloid Development
|
5R01CA026038-29
|
$344,240
|
Koeffler, H
|
CEDARS-SINAI MEDICAL CENTER
|
|
Immunoaffinity Isolation of Phosphopeptides
|
5R44CA101106-04
|
$63,319
|
RUSH, JOHN
|
CELL SIGNALING TECHNOLOGY, INC.
|
|
Variation in Ara-C Pathway Genes and Treatment Outcomes in AML
|
1R21CA119142-01A1
|
$164,365
|
GOYAL, RAKESH
|
CHILDREN'S HOSP PITTSBURGH/UPMC HLTH SYS
|
|
Cancer Biology in the Zebrafish
|
5R01CA103846-05
|
$341,771
|
ZON, LEONARD
|
CHILDREN'S HOSPITAL BOSTON
|
|
TREATMENT OF BCR/ABL CAUSED LEUKEMIAS WITH FTIs
|
2R01CA090321-06A1
|
$266,679
|
HEISTERKAMP, NORA
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Novel Ceramide-based Chemotherapy for Acute Leukemia
|
5R01CA100895-04
|
$236,830
|
MAURER, BARRY
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Prevention of insertional mutagenesis in gene therapy
|
5R01CA107492-03
|
$224,720
|
BAUM, CHRISTOPHER
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Promoting Treatment Adherence in Adolescent Leukemia
|
1R01CA119162-01A1
|
$701,307
|
DROTAR, DENNIS
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|